Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Bellevue, WA Semaglutide Injections For Medical Weight Loss | Treatment Update
Via Press Release Distribution Service
Exposures Product Safety
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Receives Positive FDA Feedback Regarding Use of LSAS in Planned Phase 3 Study
Via Investor Brand Network
Exposures Product Safety
Tickers VTGN
OMID Posts 2022 Annual Report and Provides Update
Via TheNewswire.com
Topics Cannabis
Exposures Cannabis Product Safety
Tickers OMID
OMID Posts 2022 Annual Report and Provides Update
Via News Direct
Topics Cannabis
Exposures Cannabis Product Safety
Tickers OMID
Arbutus Medical Launches TrakPak® with QuikBow™ to Improve Skeletal Traction, Announces Successful Cases
Via PRLog
Exposures Product Safety
E-Cigarette Company: Let’s get compliant!
Via TimesNewswire
Exposures Product Safety
3N Eye Care Introduces the Revolutionary Eye Contact Lenses Cleaner for Dry Eye Relief
Via TimesNewswire
Exposures Product Safety
PaxMedica, Inc. Provides Business Update and Reports Fourth Quarter 2022 Financial Results
Via NewMediaWire
Exposures Product Safety
Fort Lauderdale FL Podiatrist Has New Saorsa Swift Wart Removal Machine for Plantar Warts Treatment
Via Press Advantage
Exposures Product Safety
Bend OR Podiatrist Acquires New Saorsa Swift Wart Removal Machine for Plantar Warts Treatment
Via Press Advantage
Exposures Product Safety
Real-Time FDA Data Source On Biotech Stocks For Independent Investors Launched
Via Press Release Distribution Service
Exposures Product Safety
United Health Products Provides Update on FDA PMA Application Process
Via NewMediaWire
Topics Supply Chain
Exposures Product Safety Supply Chain
Tickers UEEC
Find Balance with Nootropa: Premium Products to Support the Mind-Body-Soul Journey
Via Get News
Exposures Product Safety
Millburn Laser Center Receives New Accure Acne Laser Treatment
Via Get News
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Revolutionary Red Light Therapy Beds Launched By Spectra Red Light
Via Get News
Exposures Product Safety
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
Via TheNewswire.com
Exposures Product Safety
Tickers OKYO
South Beach Skinlab Introduces South Beach Skincare Repair & Release Cream
Via Press Advantage
Exposures Product Safety
Creative Biolabs’ Services and Products Exclusively for Aptamer Therapeutics
Via Get News
Exposures Product Safety
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fibromyalgia
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers SILO
Neosho Allergen-Free Honey Product Manufacturer: Safety Practice Report Released
Via Press Release Distribution Service
Exposures Product Safety
New Results Medical Weight Loss Offers Game-Changing Semaglutide for Weight Loss in Mesa and Scottsdale, AZ
Via Syndication Cloud
Exposures Product Safety
Applied UV's Devices Effective Against Dangerous Pathogen Candida Auris As CDC Warns Of Rapid Spread In US Healthcare Facilities
Via News Direct
Exposures Product Safety
Tickers AUVI
Applied UV's Devices Effective Against Dangerous Pathogen Candida Auris As CDC Warns Of Rapid Spread In US Healthcare Facilities
Via TheNewswire.com
Exposures Product Safety
Tickers AUVI
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Schedules Conference Call/Webinar to Review FY 2022 Results, Discuss Corporate Updates
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Provides Statement Regarding FDA Initiative to Accelerate Approval Process for Gene Therapies
Via Investor Brand Network
Exposures Product Safety
Tickers GNPX
Jonathon’s ICL Experience Shared By Waite Vision
Via Press Advantage
Exposures Product Safety
89bio (NASDAQ: ETNB) Reports Phase 2b ENLIVEN Trial of Pegozafermin Achieved Primary Endpoints For Treatment of Nonalcoholic Steatohepatitis (NASH)
Via Spotlight Growth
Exposures Product Safety
Tickers ETNB
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Via TheNewswire.com
Exposures Product Safety
Tickers BMY GILD JNJ PFE
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Via News Direct
Exposures Product Safety
Tickers BMY GILD JNJ PFE
A marathon, not a sprint: Life with chronic myeloid leukemia
Via Brandpoint
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.